The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
Purpose The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia. Methods We performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020. Results Sixteen studies were inclu...
Saved in:
| Published in | Archives of gynecology and obstetrics Vol. 306; no. 1; pp. 173 - 187 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.07.2022
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Purpose
The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.
Methods
We performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020.
Results
Sixteen studies were included in the review. Half of them (8 studies) evaluated the cost-effectiveness of HPV vaccination in high-income countries and regions (HICs) while the other eight studies were set in low- and middle-income countries and regions (LMICs). In HICs, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination was all shown to be cost-effective. Most studies (7/8) also showed that it was cost-effective to implement bivalent, quadrivalent, and nine-valent HPV vaccines in LMICs. However, one study concluded that it was not cost-effective to implement bivalent HPV vaccination in Thailand.
Conclusion
In general, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination for adolescent girls was cost-effective in both high-income countries and regions and low- and middle-income countries and regions in Asia. Policy makers in HICs could consider expanding the target vaccinated population, while for LMICs it is essential to reduce HPV vaccine price to a level at which the implementation of HPV vaccination is cost-effective. |
|---|---|
| AbstractList | The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.PURPOSEThe aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.We performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020.METHODSWe performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020.Sixteen studies were included in the review. Half of them (8 studies) evaluated the cost-effectiveness of HPV vaccination in high-income countries and regions (HICs) while the other eight studies were set in low- and middle-income countries and regions (LMICs). In HICs, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination was all shown to be cost-effective. Most studies (7/8) also showed that it was cost-effective to implement bivalent, quadrivalent, and nine-valent HPV vaccines in LMICs. However, one study concluded that it was not cost-effective to implement bivalent HPV vaccination in Thailand.RESULTSSixteen studies were included in the review. Half of them (8 studies) evaluated the cost-effectiveness of HPV vaccination in high-income countries and regions (HICs) while the other eight studies were set in low- and middle-income countries and regions (LMICs). In HICs, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination was all shown to be cost-effective. Most studies (7/8) also showed that it was cost-effective to implement bivalent, quadrivalent, and nine-valent HPV vaccines in LMICs. However, one study concluded that it was not cost-effective to implement bivalent HPV vaccination in Thailand.In general, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination for adolescent girls was cost-effective in both high-income countries and regions and low- and middle-income countries and regions in Asia. Policy makers in HICs could consider expanding the target vaccinated population, while for LMICs it is essential to reduce HPV vaccine price to a level at which the implementation of HPV vaccination is cost-effective.CONCLUSIONIn general, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination for adolescent girls was cost-effective in both high-income countries and regions and low- and middle-income countries and regions in Asia. Policy makers in HICs could consider expanding the target vaccinated population, while for LMICs it is essential to reduce HPV vaccine price to a level at which the implementation of HPV vaccination is cost-effective. The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia. We performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020. Sixteen studies were included in the review. Half of them (8 studies) evaluated the cost-effectiveness of HPV vaccination in high-income countries and regions (HICs) while the other eight studies were set in low- and middle-income countries and regions (LMICs). In HICs, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination was all shown to be cost-effective. Most studies (7/8) also showed that it was cost-effective to implement bivalent, quadrivalent, and nine-valent HPV vaccines in LMICs. However, one study concluded that it was not cost-effective to implement bivalent HPV vaccination in Thailand. In general, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination for adolescent girls was cost-effective in both high-income countries and regions and low- and middle-income countries and regions in Asia. Policy makers in HICs could consider expanding the target vaccinated population, while for LMICs it is essential to reduce HPV vaccine price to a level at which the implementation of HPV vaccination is cost-effective. PurposeThe aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.MethodsWe performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020.ResultsSixteen studies were included in the review. Half of them (8 studies) evaluated the cost-effectiveness of HPV vaccination in high-income countries and regions (HICs) while the other eight studies were set in low- and middle-income countries and regions (LMICs). In HICs, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination was all shown to be cost-effective. Most studies (7/8) also showed that it was cost-effective to implement bivalent, quadrivalent, and nine-valent HPV vaccines in LMICs. However, one study concluded that it was not cost-effective to implement bivalent HPV vaccination in Thailand.ConclusionIn general, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination for adolescent girls was cost-effective in both high-income countries and regions and low- and middle-income countries and regions in Asia. Policy makers in HICs could consider expanding the target vaccinated population, while for LMICs it is essential to reduce HPV vaccine price to a level at which the implementation of HPV vaccination is cost-effective. Purpose The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia. Methods We performed a systematic review of papers indexed in PubMed, Scopus, and Web of Science covering the period from 1 January 2000 to 13 August 2020. Results Sixteen studies were included in the review. Half of them (8 studies) evaluated the cost-effectiveness of HPV vaccination in high-income countries and regions (HICs) while the other eight studies were set in low- and middle-income countries and regions (LMICs). In HICs, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination was all shown to be cost-effective. Most studies (7/8) also showed that it was cost-effective to implement bivalent, quadrivalent, and nine-valent HPV vaccines in LMICs. However, one study concluded that it was not cost-effective to implement bivalent HPV vaccination in Thailand. Conclusion In general, the implementation of bivalent, quadrivalent and nine-valent HPV vaccination for adolescent girls was cost-effective in both high-income countries and regions and low- and middle-income countries and regions in Asia. Policy makers in HICs could consider expanding the target vaccinated population, while for LMICs it is essential to reduce HPV vaccine price to a level at which the implementation of HPV vaccination is cost-effective. |
| Author | Tian, Yuke Dong, Xiaomei Akinwunmi, Babatunde O. Zhang, Casper J. P. Huang, Jian Zhu, Ke Ming, Wai-kit |
| Author_xml | – sequence: 1 givenname: Ke surname: Zhu fullname: Zhu, Ke organization: Department of Public Health and Preventive Medicine, School of Medicine, Jinan University – sequence: 2 givenname: Yuke surname: Tian fullname: Tian, Yuke organization: Department of Medical Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China – sequence: 3 givenname: Xiaomei surname: Dong fullname: Dong, Xiaomei organization: Department of Public Health and Preventive Medicine, School of Medicine, Jinan University – sequence: 4 givenname: Babatunde O. surname: Akinwunmi fullname: Akinwunmi, Babatunde O. organization: Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Harvard Medical School – sequence: 5 givenname: Casper J. P. surname: Zhang fullname: Zhang, Casper J. P. organization: School of Public Health, LSK Faculty of Medicine, The University of Hong Kong – sequence: 6 givenname: Jian surname: Huang fullname: Huang, Jian organization: Singapore Institute for Clinical Sciences (SICS), the Agency for Science, Technology and Research (ASTAR) – sequence: 7 givenname: Wai-kit surname: Ming fullname: Ming, Wai-kit email: wkming@connect.hku.hk organization: Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35380278$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kUFP3DAQhS0EKrDtH-CALHHpoaZjJ7Edbgi1pRISHGivlteZgFHWAdtZtP--LqFQceBke_Q9z8x7-2Q7jAEJOeBwzAHU1wRQQ81AcAaygpZttsgeryvBQHG-_d99l-yndAfAhdbyA9mtmkqDUHqPhOtbpG5MmWHfo8t-jQFTomNPl35tBwz5C32YbBdfXjZ0NPiAbC7Q86vfdG2d88FmPwbqAz1N3p5QS9MmZVyVsqMR1x4fP5Kd3g4JPz2fC_Lr-7frs3N2cfnj59npBXMVNJnJvunaVrVa1hxcw1ulOEiHQpaV66V2nVROdsI5vixAzduur3u0TmnoLDbVgnye_72P48OEKZuVTw6HwQYcp2SErJXgXDSioEdv0LtxiqFMV6iW61ar4u6CHD5T03KFnbmPfmXjxvxzsgBiBlwcU4rYvyAczN-4zByXKXGZp7jMpoj0G5Hz-cnFHK0f3pdWszSVPuEG4-vY76j-AP02qSA |
| CitedBy_id | crossref_primary_10_1002_jmv_29910 crossref_primary_10_3389_fimmu_2023_1197191 crossref_primary_10_3390_cancers15184501 crossref_primary_10_3390_vaccines12060689 crossref_primary_10_1016_j_lansea_2023_100316 |
| Cites_doi | 10.1186/1471-2458-11-203 10.1016/s0140-6736(07)61416-0 10.1136/bmjopen-2019-031186 10.1016/s2214-109x(16)30099-7 10.11622/smedj.2017085 10.1016/j.vhri.2013.02.001 10.31557/apjcp.2019.20.2.425 10.1111/1471-0528.15106 10.1016/s0002-9343(97)00177-0 10.1186/s12913-016-1662-5 10.1016/j.vaccine.2005.09.002 10.1016/j.ygyno.2008.07.045 10.1016/j.vaccine.2019.10.037 10.22034/apjcp.2017.18.7.2011 10.1016/j.vaccine.2013.10.081 10.1016/j.jval.2013.02.010 10.1186/s12885-016-2893-x 10.31557/APJCP.2019.20.5.1377 10.1002/ijc.29082 10.1016/j.vaccine.2012.04.108 10.1016/j.vaccine.2014.12.067 10.1056/NEJMoa021641 10.2165/11586560-000000000-00000 10.1002/ijgo.12126 10.1186/s12879-017-2592-5 10.1128/jcm.33.8.2058-2063.1995 10.1016/0304-419x(96)00020-0 10.1016/s1473-3099(14)71073-4 10.1158/1055-9965.Epi-04-0551 10.1071/sh14241 10.1086/597307 10.3322/caac.21660 10.1016/j.vaccine.2019.12.013 10.1016/j.vaccine.2017.05.069 10.1186/1471-2407-14-365 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 – notice: 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S PQEST PQQKQ PQUKI 7X8 |
| DOI | 10.1007/s00404-021-06309-y |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central (New) ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed ProQuest One Academic Eastern Edition |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-0711 |
| EndPage | 187 |
| ExternalDocumentID | 35380278 10_1007_s00404_021_06309_y |
| Genre | Journal Article |
| GeographicLocations | Asia |
| GeographicLocations_xml | – name: Asia |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 1N0 2.D 203 23N 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 7X7 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AAJSJ AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACGFS ACHSB ACHVE ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACUDM ACULB ACZOJ ADBBV ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PT4 PT5 QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z8O Z8V Z8W Z91 ZMTXR ZOVNA ZXP ~EX AAPKM AAYXX ABBRH ABDBE ABEEZ ABFSG ACSTC ADHKG AEZWR AFDZB AFGXO AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION NPM 3V. 7XB 8FK K9. PQEST PQUKI 7X8 |
| ID | FETCH-LOGICAL-c305t-6f5d997986410c51977106ce260044b8cd67c6d2cc1b10c419df4feac780dae53 |
| IEDL.DBID | U2A |
| ISSN | 1432-0711 0932-0067 |
| IngestDate | Fri Jul 11 16:15:38 EDT 2025 Mon Jun 30 15:12:36 EDT 2025 Wed Feb 19 02:26:10 EST 2025 Tue Jul 01 01:35:29 EDT 2025 Thu Apr 24 23:08:53 EDT 2025 Fri Feb 21 02:45:02 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Systematic review HPV vaccination Asia Cost-effectiveness |
| Language | English |
| License | 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c305t-6f5d997986410c51977106ce260044b8cd67c6d2cc1b10c419df4feac780dae53 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 35380278 |
| PQID | 2691898706 |
| PQPubID | 4408561 |
| PageCount | 15 |
| ParticipantIDs | proquest_miscellaneous_2647211252 proquest_journals_2691898706 pubmed_primary_35380278 crossref_primary_10_1007_s00404_021_06309_y crossref_citationtrail_10_1007_s00404_021_06309_y springer_journals_10_1007_s00404_021_06309_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-07-01 |
| PublicationDateYYYYMMDD | 2022-07-01 |
| PublicationDate_xml | – month: 07 year: 2022 text: 2022-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Archives of gynecology and obstetrics |
| PublicationTitleAbbrev | Arch Gynecol Obstet |
| PublicationTitleAlternate | Arch Gynecol Obstet |
| PublicationYear | 2022 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Tay, Lee, Sohn, Lee, Mathur, Sanicas, Van Kriekinge (CR24) 2018; 59 Koutsky (CR8) 1997; 102 Dochez, Bogers, Verhelst, Rees (CR4) 2014; 32 Tang, Cheng, Jiang, You, Huang, Hsieh, Lee (CR25) 2019; 20 Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal (CR1) 2021 Stanley (CR9) 2006; 24 Brown, Kjaer, Sigurdsson, Iversen, Hernandez-Avila, Wheeler, Barr (CR16) 2009; 199 CR18 CR17 Drolet, Bénard, Boily, Ali, Baandrup, Bauer, Brisson (CR13) 2015; 15 Mahumud, Gow, Alam, Keramat, Hossain, Sultana, Islam (CR34) 2020; 38 (CR11) 2017; 35 Demarteau, Morhason-Bello, Akinwunmi, Adewole (CR37) 2014; 14 Giuliano, Nyitray, Kreimer, Pierce Campbell, Goodman, Sudenga, Franceschi (CR5) 2015; 136 Lee, Tay, Teoh, Tok (CR23) 2011; 11 Muñoz, Bosch, de Sanjosé, Herrero, Castellsagué, Shah, Meijer (CR14) 2003; 348 Mo, Tobe, Wang, Liu, Wu, Luo, Nakayama (CR36) 2017 Praditsitthikorn, Teerawattananon, Tantivess, Limwattananon, Riewpaiboon, Chichareon, Tangcharoensathien (CR31) 2011; 29 Anwari, Debellut, Vodicka, Clark, Farewar, Zhwak, Safi (CR33) 2020; 38 Kosen, Andrijono, Ocviyanti, Indriatmi (CR35) 2017; 18 CR3 Connelly, Le (CR21) 2015; 12 Chanthavilay, Reinharz, Mayxay, Phongsavan, Marsden, Moore, White (CR29) 2016; 16 Jiang, Ni, Wu (CR30) 2019; 9 Tay, Hsu, Pavelyev, Walia, Kulkarni (CR28) 2018; 125 Greer, Wheeler, Ladner, Beutner, Coyne, Liang, Ralston (CR15) 1995; 33 Husereau, Drummond, Petrou, Carswell, Moher, Greenberg, Loder (CR19) 2013; 16 Schiffman, Castle, Jeronimo, Rodriguez, Wacholder (CR10) 2007; 370 Lee, Hur, Jang, Lee, Sohn, Van Kriekinge, Kim (CR22) 2019; 20 CR20 Zhang, Liu, Hu, Zhao (CR32) 2016 Yamabe, Singhal, Abe, Dasbach, Elbasha (CR26) 2013; 2 zzur Hausen (CR2) 1996; 1288 Tay, Hsu, Shcheprov, Walia, Kulkarni (CR27) 2017; 137 Castellsagué (CR7) 2008; 110 Kreimer, Clifford, Boyle, Franceschi (CR6) 2005; 14 Aguilar, Mendoza, García, Díaz, Figueroa, Duarte, Janusz (CR38) 2015; 33 Bruni, Diaz, Barrionuevo-Rosas, Herrero, Bray, Bosch, Castellsagué (CR39) 2016; 4 Schiller, Castellsagué, Garland (CR12) 2012; 30 Suppl 5 SK Tay (6309_CR28) 2018; 125 S Kosen (6309_CR35) 2017; 18 L Bruni (6309_CR39) 2016; 4 AR Giuliano (6309_CR5) 2015; 136 RA Mahumud (6309_CR34) 2020; 38 N Demarteau (6309_CR37) 2014; 14 C Dochez (6309_CR4) 2014; 32 N Muñoz (6309_CR14) 2003; 348 M Schiffman (6309_CR10) 2007; 370 Y Jiang (6309_CR30) 2019; 9 H zzur Hausen (6309_CR2) 1996; 1288 AR Kreimer (6309_CR6) 2005; 14 P Anwari (6309_CR33) 2020; 38 X Castellsagué (6309_CR7) 2008; 110 M Stanley (6309_CR9) 2006; 24 6309_CR20 N Praditsitthikorn (6309_CR31) 2011; 29 SK Tay (6309_CR27) 2017; 137 JT Schiller (6309_CR12) 2012; 30 Suppl 5 M Drolet (6309_CR13) 2015; 15 World Health Organization (6309_CR11) 2017; 35 DR Brown (6309_CR16) 2009; 199 VJ Lee (6309_CR23) 2011; 11 Q Zhang (6309_CR32) 2016 C-H Tang (6309_CR25) 2019; 20 IB Aguilar (6309_CR38) 2015; 33 H Sung (6309_CR1) 2021 L Koutsky (6309_CR8) 1997; 102 LB Connelly (6309_CR21) 2015; 12 D Husereau (6309_CR19) 2013; 16 K Yamabe (6309_CR26) 2013; 2 X Mo (6309_CR36) 2017 6309_CR18 SK Tay (6309_CR24) 2018; 59 6309_CR17 H Lee (6309_CR22) 2019; 20 P Chanthavilay (6309_CR29) 2016; 16 6309_CR3 CE Greer (6309_CR15) 1995; 33 |
| References_xml | – volume: 11 start-page: 203 year: 2011 ident: CR23 article-title: Cost-effectiveness of different human papillomavirus vaccines in Singapore publication-title: BMC Public Health doi: 10.1186/1471-2458-11-203 – volume: 370 start-page: 890 issue: 9590 year: 2007 end-page: 907 ident: CR10 article-title: Human papillomavirus and cervical cancer publication-title: Lancet doi: 10.1016/s0140-6736(07)61416-0 – ident: CR18 – volume: 9 issue: 11 year: 2019 ident: CR30 article-title: Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis publication-title: BMJ Open doi: 10.1136/bmjopen-2019-031186 – volume: 4 start-page: e453 issue: 7 year: 2016 end-page: 463 ident: CR39 article-title: Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis publication-title: Lancet Glob Health doi: 10.1016/s2214-109x(16)30099-7 – volume: 59 start-page: 370 issue: 7 year: 2018 end-page: 382 ident: CR24 article-title: Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore publication-title: Singapore Med J doi: 10.11622/smedj.2017085 – volume: 2 start-page: 92 issue: 1 year: 2013 end-page: 97 ident: CR26 article-title: The cost-effectiveness analysis of a quadrivalent human papillomavirus vaccine (6/11/16/18) for females in Japan publication-title: Value Health Reg Issues doi: 10.1016/j.vhri.2013.02.001 – volume: 20 start-page: 425 issue: 2 year: 2019 end-page: 435 ident: CR22 article-title: Cost-utility of a two-dose human papillomavirus vaccination programme added to cervical cancer screening compared with cervical cancer screening alone in Korea publication-title: Asian Pac J Cancer Prev doi: 10.31557/apjcp.2019.20.2.425 – volume: 125 start-page: 478 issue: 4 year: 2018 end-page: 486 ident: CR28 article-title: Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis publication-title: BJOG doi: 10.1111/1471-0528.15106 – volume: 102 start-page: 3 issue: 5a year: 1997 end-page: 8 ident: CR8 article-title: Epidemiology of genital human papillomavirus infection publication-title: Am J Med doi: 10.1016/s0002-9343(97)00177-0 – volume: 16 start-page: 418 issue: 1 year: 2016 ident: CR29 article-title: The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: a mathematical modelling approach publication-title: BMC Health Serv Res doi: 10.1186/s12913-016-1662-5 – volume: 24 start-page: S16 issue: Suppl 1 year: 2006 end-page: 22 ident: CR9 article-title: Immune responses to human papillomavirus publication-title: Vaccine doi: 10.1016/j.vaccine.2005.09.002 – volume: 110 start-page: S4 issue: 3 Suppl 2 year: 2008 end-page: 7 ident: CR7 article-title: Natural history and epidemiology of HPV infection and cervical cancer publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.07.045 – volume: 38 start-page: 165 issue: 2 year: 2020 end-page: 172 ident: CR34 article-title: Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh publication-title: Vaccine doi: 10.1016/j.vaccine.2019.10.037 – volume: 18 start-page: 2011 issue: 7 year: 2017 end-page: 2017 ident: CR35 article-title: The cost-effectiveness of quadrivalent human papillomavirus vaccination in Indonesia publication-title: Asian Pac J Cancer Prev doi: 10.22034/apjcp.2017.18.7.2011 – volume: 32 start-page: 1595 issue: 14 year: 2014 end-page: 1601 ident: CR4 article-title: HPV vaccines to prevent cervical cancer and genital warts: an update publication-title: Vaccine doi: 10.1016/j.vaccine.2013.10.081 – volume: 16 start-page: e1 issue: 2 year: 2013 end-page: 5 ident: CR19 article-title: Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement publication-title: Value Health doi: 10.1016/j.jval.2013.02.010 – year: 2016 ident: CR32 article-title: Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in China publication-title: BMC Cancer doi: 10.1186/s12885-016-2893-x – volume: 20 start-page: 1377 issue: 5 year: 2019 end-page: 1387 ident: CR25 article-title: Cost-effectiveness analysis of human papillomavirus vaccination in adolescent girls in Taiwan publication-title: Asian Pac J Cancer Prev: APJCP doi: 10.31557/APJCP.2019.20.5.1377 – volume: 136 start-page: 2752 issue: 12 year: 2015 end-page: 2760 ident: CR5 article-title: EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection publication-title: Int J Cancer doi: 10.1002/ijc.29082 – volume: 30 Suppl 5 start-page: F123 issue: 05 year: 2012 end-page: 138 ident: CR12 article-title: A review of clinical trials of human papillomavirus prophylactic vaccines publication-title: Vaccine doi: 10.1016/j.vaccine.2012.04.108 – volume: 33 start-page: A167 issue: Suppl 1 year: 2015 end-page: 173 ident: CR38 article-title: Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras publication-title: Vaccine doi: 10.1016/j.vaccine.2014.12.067 – volume: 348 start-page: 518 issue: 6 year: 2003 end-page: 527 ident: CR14 article-title: Epidemiologic classification of human papillomavirus types associated with cervical cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa021641 – volume: 29 start-page: 781 issue: 9 year: 2011 end-page: 806 ident: CR31 article-title: Economic evaluation of policy options for prevention and control of cervical cancer in Thailand publication-title: Pharmacoeconomics doi: 10.2165/11586560-000000000-00000 – volume: 137 start-page: 129 issue: 2 year: 2017 end-page: 137 ident: CR27 article-title: The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore publication-title: Int J Gynaecol Obstet doi: 10.1002/ijgo.12126 – ident: CR3 – ident: CR17 – year: 2017 ident: CR36 article-title: Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China publication-title: BMC Infect Dis doi: 10.1186/s12879-017-2592-5 – volume: 33 start-page: 2058 issue: 8 year: 1995 end-page: 2063 ident: CR15 article-title: Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts publication-title: J Clin Microbiol doi: 10.1128/jcm.33.8.2058-2063.1995 – volume: 1288 start-page: F55 issue: 2 year: 1996 end-page: 78 ident: CR2 article-title: Papillomavirus infections—a major cause of human cancers publication-title: Biochim Biophys Acta doi: 10.1016/0304-419x(96)00020-0 – volume: 15 start-page: 565 issue: 5 year: 2015 end-page: 580 ident: CR13 article-title: Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/s1473-3099(14)71073-4 – volume: 14 start-page: 467 issue: 2 year: 2005 end-page: 475 ident: CR6 article-title: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.Epi-04-0551 – volume: 12 start-page: 520 issue: 6 year: 2015 end-page: 531 ident: CR21 article-title: Cost-effectiveness of a bivalent human papillomavirus vaccination program in Japan publication-title: Sex Health doi: 10.1071/sh14241 – volume: 199 start-page: 926 issue: 7 year: 2009 end-page: 935 ident: CR16 article-title: The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16–26 years publication-title: J Infect Dis doi: 10.1086/597307 – year: 2021 ident: CR1 article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 38 start-page: 1352 issue: 6 year: 2020 end-page: 1362 ident: CR33 article-title: Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan publication-title: Vaccine doi: 10.1016/j.vaccine.2019.12.013 – volume: 35 start-page: 5753 issue: 43 year: 2017 end-page: 5755 ident: CR11 article-title: Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations publication-title: Vaccine doi: 10.1016/j.vaccine.2017.05.069 – ident: CR20 – volume: 14 start-page: 365 year: 2014 ident: CR37 article-title: Modeling optimal cervical cancer prevention strategies in Nigeria publication-title: BMC Cancer doi: 10.1186/1471-2407-14-365 – volume: 59 start-page: 370 issue: 7 year: 2018 ident: 6309_CR24 publication-title: Singapore Med J doi: 10.11622/smedj.2017085 – volume: 20 start-page: 425 issue: 2 year: 2019 ident: 6309_CR22 publication-title: Asian Pac J Cancer Prev doi: 10.31557/apjcp.2019.20.2.425 – volume: 2 start-page: 92 issue: 1 year: 2013 ident: 6309_CR26 publication-title: Value Health Reg Issues doi: 10.1016/j.vhri.2013.02.001 – year: 2016 ident: 6309_CR32 publication-title: BMC Cancer doi: 10.1186/s12885-016-2893-x – volume: 18 start-page: 2011 issue: 7 year: 2017 ident: 6309_CR35 publication-title: Asian Pac J Cancer Prev doi: 10.22034/apjcp.2017.18.7.2011 – year: 2017 ident: 6309_CR36 publication-title: BMC Infect Dis doi: 10.1186/s12879-017-2592-5 – volume: 33 start-page: A167 issue: Suppl 1 year: 2015 ident: 6309_CR38 publication-title: Vaccine doi: 10.1016/j.vaccine.2014.12.067 – ident: 6309_CR20 – volume: 14 start-page: 365 year: 2014 ident: 6309_CR37 publication-title: BMC Cancer doi: 10.1186/1471-2407-14-365 – volume: 11 start-page: 203 year: 2011 ident: 6309_CR23 publication-title: BMC Public Health doi: 10.1186/1471-2458-11-203 – volume: 9 issue: 11 year: 2019 ident: 6309_CR30 publication-title: BMJ Open doi: 10.1136/bmjopen-2019-031186 – volume: 12 start-page: 520 issue: 6 year: 2015 ident: 6309_CR21 publication-title: Sex Health doi: 10.1071/sh14241 – volume: 29 start-page: 781 issue: 9 year: 2011 ident: 6309_CR31 publication-title: Pharmacoeconomics doi: 10.2165/11586560-000000000-00000 – volume: 125 start-page: 478 issue: 4 year: 2018 ident: 6309_CR28 publication-title: BJOG doi: 10.1111/1471-0528.15106 – year: 2021 ident: 6309_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 – volume: 32 start-page: 1595 issue: 14 year: 2014 ident: 6309_CR4 publication-title: Vaccine doi: 10.1016/j.vaccine.2013.10.081 – volume: 33 start-page: 2058 issue: 8 year: 1995 ident: 6309_CR15 publication-title: J Clin Microbiol doi: 10.1128/jcm.33.8.2058-2063.1995 – volume: 38 start-page: 1352 issue: 6 year: 2020 ident: 6309_CR33 publication-title: Vaccine doi: 10.1016/j.vaccine.2019.12.013 – volume: 110 start-page: S4 issue: 3 Suppl 2 year: 2008 ident: 6309_CR7 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.07.045 – volume: 16 start-page: e1 issue: 2 year: 2013 ident: 6309_CR19 publication-title: Value Health doi: 10.1016/j.jval.2013.02.010 – volume: 20 start-page: 1377 issue: 5 year: 2019 ident: 6309_CR25 publication-title: Asian Pac J Cancer Prev: APJCP doi: 10.31557/APJCP.2019.20.5.1377 – volume: 102 start-page: 3 issue: 5a year: 1997 ident: 6309_CR8 publication-title: Am J Med doi: 10.1016/s0002-9343(97)00177-0 – ident: 6309_CR17 – volume: 370 start-page: 890 issue: 9590 year: 2007 ident: 6309_CR10 publication-title: Lancet doi: 10.1016/s0140-6736(07)61416-0 – ident: 6309_CR3 – volume: 14 start-page: 467 issue: 2 year: 2005 ident: 6309_CR6 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.Epi-04-0551 – volume: 16 start-page: 418 issue: 1 year: 2016 ident: 6309_CR29 publication-title: BMC Health Serv Res doi: 10.1186/s12913-016-1662-5 – volume: 4 start-page: e453 issue: 7 year: 2016 ident: 6309_CR39 publication-title: Lancet Glob Health doi: 10.1016/s2214-109x(16)30099-7 – volume: 24 start-page: S16 issue: Suppl 1 year: 2006 ident: 6309_CR9 publication-title: Vaccine doi: 10.1016/j.vaccine.2005.09.002 – volume: 348 start-page: 518 issue: 6 year: 2003 ident: 6309_CR14 publication-title: N Engl J Med doi: 10.1056/NEJMoa021641 – volume: 15 start-page: 565 issue: 5 year: 2015 ident: 6309_CR13 publication-title: Lancet Infect Dis doi: 10.1016/s1473-3099(14)71073-4 – volume: 30 Suppl 5 start-page: F123 issue: 05 year: 2012 ident: 6309_CR12 publication-title: Vaccine doi: 10.1016/j.vaccine.2012.04.108 – volume: 136 start-page: 2752 issue: 12 year: 2015 ident: 6309_CR5 publication-title: Int J Cancer doi: 10.1002/ijc.29082 – volume: 137 start-page: 129 issue: 2 year: 2017 ident: 6309_CR27 publication-title: Int J Gynaecol Obstet doi: 10.1002/ijgo.12126 – volume: 38 start-page: 165 issue: 2 year: 2020 ident: 6309_CR34 publication-title: Vaccine doi: 10.1016/j.vaccine.2019.10.037 – volume: 35 start-page: 5753 issue: 43 year: 2017 ident: 6309_CR11 publication-title: Vaccine doi: 10.1016/j.vaccine.2017.05.069 – volume: 1288 start-page: F55 issue: 2 year: 1996 ident: 6309_CR2 publication-title: Biochim Biophys Acta doi: 10.1016/0304-419x(96)00020-0 – ident: 6309_CR18 – volume: 199 start-page: 926 issue: 7 year: 2009 ident: 6309_CR16 publication-title: J Infect Dis doi: 10.1086/597307 |
| SSID | ssj0012886 |
| Score | 2.332109 |
| Snippet | Purpose
The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.
Methods
We performed a systematic review of... The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia. We performed a systematic review of papers indexed in... PurposeThe aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.MethodsWe performed a systematic review of papers... The aim of this study was to systematically review the cost-effectiveness of HPV vaccination in Asia.PURPOSEThe aim of this study was to systematically review... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 173 |
| SubjectTerms | Cost analysis Endocrinology Gynecologic Oncology Gynecology Human Genetics Immunization Low income groups Medicine Medicine & Public Health Obstetrics/Perinatology/Midwifery Systematic review |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Na9sw9LFmUHop3frlrRsa9NaKRo7s2L2UMhbCIGOHteRmpCcbAsVOm6SQf9_3ZMWhlPVoW5LF-5beF8B5STpYWyT-7mel1IgobeKsHLCuttwcFjlRePInHd_p39NkGi7cFiGsciMTvaB2DfId-VWc5irL2St3M3-U3DWKvauhhcYOfOTSZUzVw2l34CLR6zs90qE9liyWQ9KMT51j6tWSAxS46lQu168V0xtr842n1Cug0QHsB8tR3Lao_gQfyvoz7E6Cb_wQasK4wGaxlG2MRhBjoqmEnRE9kXa5FI8r4566J1M7UdNk2b4Q47_34tkgrefxJWa1uF3MzLUwYlvxWbTZLkdwN_r17-dYhm4KEomnlzKtEpfnQy7HrvrI-apkXHA_sJSdujZDlw4xdTGiIhyhVrmrdEVyeZj1nSmTwTH06qYuT0HEyqjEVjZRJtOmSnPMM2cVESVWqct0BGoDygJDqXHuePFQdEWSPfgLAn_hwV-sI7jo5szbQhvvjj7bYKgITLcotiQSwY_uM7EL-0BMXTYrHqP5zBsncQQnLWa73w1I-LMjNoLLDaq3i_9_L1_e38tX2Is5ZcKH-J5Bb_m0Kr-RIbO03z21vgAc9O3O priority: 102 providerName: ProQuest |
| Title | The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review |
| URI | https://link.springer.com/article/10.1007/s00404-021-06309-y https://www.ncbi.nlm.nih.gov/pubmed/35380278 https://www.proquest.com/docview/2691898706 https://www.proquest.com/docview/2647211252 |
| Volume | 306 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED_WFsZeSrtPr23QYG-rIHJkWd5bFtKFjZZSmpE9GelkQ6A4a5MM-t_vzl9ldBvsydiWZHMfuhO_-wB4X5AN1h5Jv4e2kBoRpU-ClyO21Z6bwyInCp9fmNlcf1kkizYpbN1Fu3eQZL1T98luLG9ackgB14nK5P0O7CV0dudArnk87rGD2FrTpsf8ed7vJuiRX_kIE61NzdkB7Lc-ohg3TD2EJ0X1HJ6etyj4C6iItwJX641sojHaDUusSuGXJDlkR07F7daFu_7OVUFUNFk2D8Ts8pv46ZDWqzkjlpUYr5fuo3DiobazaPJaXsL8bHo9mcm2b4JE0t6NNGUSsizlwutqiJyZSm4Ed_4yDN96i8GkaEKMqIgbqFUWSl3SDpzaYXBFMnoFu9WqKt6AiJVTiS99opzVrjQZZjZ4ReKHpQlWR6A6UubYFhXn3hY3eV8OuSZ_TuTPa_Ln9xF86Of8aEpq_HP0ccehvFWvdR6bTNmMIdoI3vWvSTEY7XBVsdryGM2n2ziJI3jdcLb_3Ii2eYZcIzjtWP2w-N__5e3_DT-CZzEnS9TBvcewu7nbFifkwmz8AHbSRTqAvfHn71-ndP00vbi8oqcTMxnU0vwLN-ruJg |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dS9xAEB_EQtsXUfsVtXUL7VNdmo2bXFIoIm3lrJ70Qcu9pbuzCRyURL27yv1T_o2d2XwcReqbj0l2k2V2Zn47mS-AdwVhsLZI8h2mhdSIKG3srNxnrLbcHBY5UXh0lgwv9PdxPF6B2y4XhsMqO53oFbWrkf-Rf4ySTKUZe-UOLq8kd41i72rXQqNhi5NicUMm2_Tz8Vfa3_dRdPTt_MtQtl0FJBJvz2RSxi7LBlyWXIXIeZsEstwXK2Hnpk3RJQNMXISoaK2oVeZKXZJ-GqShMwV3iSCV_4iAN2RjbzDuDTxS9b6zZEhnIskw0Cbp-FQ9lhYtOSCCq1xlcvEvEN453d7xzHrAO1qHtfakKg4b1tqAlaLahMej1hf_DCriMIH1dCabmJBWbYq6FHZC_Etotieu5sZd91emcqKiybK5IYY_foo_Bul9nj_EpBKH04n5JIxYVpgWTXbNc7h4EDq_gNWqropXICJlVGxLGyuTalMmGWaps4qEAMvEpToA1ZEyx7a0OXfY-J33RZk9-XMif-7Jny8C-NDPuWwKe9w7eqfbobwV8mm-ZMkA3vaPSTzZ52Kqop7zGM02dhRHAbxsdrb_3D6BDTt-A9jrtnr58v-vZev-tezCk-H56DQ_PT472YanEadr-PDiHVidXc-L13SImtk3nnMF_HpoUfkLm1sqIg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9KheKL2Pq1ttYI-mRDL2k2lxV8OKzH1drSB0_6tuZjFw4kV3t7Lfdf-Sc6s19FqoIPfdzdJBsmM5mE3_xmAF4X6IOV82jfA1Nw5b3nLg2OH5CvdlQc1hNR-ORUT6bq03l6vgY_Oy5MHe3eQZINp4GyNMVq_yKU-z3xjXRPcQovoJxRGV-1YZXHxeoaL22L90eHuMJvpBx__PJhwtu6Atyjdldcl2nIsiElJhcDT8xNdLNUGUsTvOmMD3rodZDeC5ytVyILpSpxhxqaQbAF1YnATf-eIvYxWtBUjnrcQhqjW2rOn-f5u_u7daa9hcfWbm78EB6051M2ahRqE9aKuAUbJy0C_wgi6hXz80XFm0iQdrNk85K5GWotynCP_VjacNk_2RhYxM68ecEmZ1_ZlfU4Xq0VbBbZaDGz75hlN3mlWcOpeQzTO5HtE1iP81g8AyaFFakrXSqsUbbUmc9McAJV35c6GJWA6ESZ-zahOdXV-J73qZhr8eco_rwWf75K4G3f56JJ5_HP1jvdCuWtaS9yqTNhMoKHE3jVf0ajJKTFxmK-pDaKbtYylQk8bVa2_90BuhiCexPY65b6ZvC_z-X5_zV_CRtnh-P889Hp8Tbcl8TZqGOMd2C9ulwWL_AkVbndWnkZfLtra_kF3msp5w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+cost-effectiveness+of+bivalent%2C+quadrivalent%2C+and+nine-valent+HPV+vaccination+in+Asia%3A+a+systematic+review&rft.jtitle=Archives+of+gynecology+and+obstetrics&rft.au=Zhu%2C+Ke&rft.au=Tian%2C+Yuke&rft.au=Dong%2C+Xiaomei&rft.au=Akinwunmi%2C+Babatunde+O&rft.date=2022-07-01&rft.eissn=1432-0711&rft_id=info:doi/10.1007%2Fs00404-021-06309-y&rft_id=info%3Apmid%2F35380278&rft.externalDocID=35380278 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1432-0711&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1432-0711&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1432-0711&client=summon |